Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. Gilead’s work in liver diseases includes a portfolio of products and a pipeline of investigational drugs in viral hepatitis (hepatitis B and hepatitis C), non-alcoholic steatohepatitis (NASH) and primary sclerosing cholangitis (PSC). Gilead’s partnerships in science, academia, business and local communities enhance its ability to develop innovative medicines and deliver them to people as efficiently as possible.

[ Ссылка ]

свернуть